Hemodynamic characteristics of vasopressin in dogs with severe hemorrhagic shock

Journal of Veterinary Medical Science

Volumn 68, Issue 9, 2006, Pages 967-972

  Yoo, Jong Hyun ^a   Kim, Min Su ^a   Park, Hee Myung ^b  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Canine; Epinephrine; Hemodynamics; Hemorrhagic shock; Vasopressin

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; VASOPRESSIN DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; DRUG EFFECT; FEMALE; HEMORRHAGIC SHOCK; MALE; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; DOG DISEASES; DOGS; EPINEPHRINE; FEMALE; MALE; SHOCK, HEMORRHAGIC; SYMPATHOMIMETICS; VASOPRESSINS;

CANIS FAMILIARIS;

EID: 33749535039     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.68.967     Document Type: Article

References (27)

1. Bboud, F. M., Floras, J. S., Aylward, P. E., Guo, G. B., Gupta, B. N. and Schmid, P. G. 1990. Role of vasopressin in cardiovascular and blood pressure regulation. Blood Vessels 27: 106-115.
2. Adams, H.R. and Parker, J.L. 1979. Pharmacologic management of circulatory shock: cardiovascular drugs and corticosteroids. J. Am. Vet. Med. Assoc. 175: 86-92
3. Blinman, T. and Maggard, M. 2000. Rational manipulation of oxygen delivery. J. Surg. Res. 92: 120-141.
4. Cervera, A. L. and Moss, G. 1975. Progressive hypovolemia leading to shock after continuous hemorrhage and 3:1 crystalloid replacement. Am. J. Surg. 129: 670-674.
5. DiBartola, S. P. 2000. Fluid Theraphy in Small Animal Practice. 2nd, ed. W.B. Saunders Company, Philadelphia.
6. Gore, J.M., Goldberg, R.J., Spodick, D.H., Alpert, J.S. and Dalen, J.E. 1987. A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest 92: 721-727.
7. Holmes, C. L., Walley, K. R., Chittock, D. R., Lehman, T. and Russell, J. A. 2001. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med. 27: 1416-1421.
8. Jeong, S. M. 2002. Effects of electroacupuncture on minimum alveolar concentration of isoflurane and cardiovascular system in isoflurane anesthetized dogs. J. Vet. Sci. 3: 193-201.
9. Klinzing, S., Simon, M., Reinhart, K., Bredle, D. L. and Meier-Hellmann, A. 2003. High-dose vasopressin is not superior to norepinephrine in septic shock. Crit. Care Med. 31: 2646-2650.
10. Krismer, A.C., Wenzel, V., Mayr, V.D., Voelckel, W.G., Strohmenger, H.U., Lurie, K. and Lindner, K.H. 2001. Arginine vasopressin during cardiopulmonary resuscitation and vasodilatory shock: current experience and future perspectives. Curr. Opin. Crit. Care. 7: 157-169.
11. Lindner, K. H., Strohmenger, H. U., Ensinger, H., Hetzel, W. D., Ahnefeld, F. W. and Georgieff, M. 1992. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology 77: 662-668.
12. Mellema, M. 2001. Cardiac output, wedge pressure, and oxygen delivery. Vet. Clin. North Am. Small Anim. Pract. 31: 1175-1205.
13. Mink, S.N., Bands, C., Becker, A., Elkin, J., Sharma, S., Unruh, H. and Kepron, W. 1998. Effect of bolus epinephrine on systemic hemodynamics in canine anaphylactic shock. Cardiovasc. Res. 40: 546-556.
14. Mink, S.N., Simons, F.E., Simons, K.J., Becker, A.B. and Duke, K. 2004. Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clin. Exp. Allergy 34: 1776-1783.
15. Morales, D., Madigan, J., Cullinane, S., Chen, J., Heath, M., Oz, M., Oliver, J.A. and Landry, D. W. 1999. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 100: 226-229.
16. Ordin, A., Makisalo, H. and Hockerstedt, K. 1994. Dopamine infusion during resuscitation of experimental hemorrhagic shock. Crit. Care Med. 22: 151-156.
17. Pope, A., French, G. and Longnecker, A. E. 1999. Fluid Resuscitation. State of the Science for Treating Combat Casualies and Civilian Injuries. National academy Press, Washington, D.C.
18. Prengel, A. W., Lindner, K. H., Keller, A. and Lurie, K. G. 1996. Cardiovascular function during the postresuscitation phase after cardiac arrest in pigs: a comparison of epinephrine versus vasopressin. Crit. Care Med. 24: 2014-2019.
19. Rudichenko, V.M. and Beierwaltes, W.H. 1995. Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. J. Vasc. Res. 32: 100-105.
20. Rudloff, E. and Kirby, R. 1994. Hypovolemic shock and resuscitation. Vet. Clin. North Am. Small Anim. Pract. 24: 1015-1039.
21. Rudloff, E. and Kirby, R. 2001. Colloid and crystalloid resuscitation. Vet. Clin. North Am. Small Anim. Pract. 31: 1207-1229.
22. Shoemaker, W.C. and Czer, L.S. 1979. Evaluation of the biologic importance of various hemodynamic and oxygen transport variables: which variables should be monitored in postoperative shock? Crit. Care Med. 7: 424-431.
23. Stadlbauer, K. H., Wagner-Berger, H. G., Raedler, C., Voelckel, W. G., Wenzel, V., Krismer, A. C., Klima, G., Rheinberger, K., Nussbaumer, W., Pressmar, D., Lindner, K. H. and Konigsrainer, A. 2003. Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs. Anesthesiology 98: 699-704.
24. Voelckel, W. G., Raedler, C., Wenzel, V., Lindner, K. H., Krismer, A. C., Schmittinger, C. A., Herff, H., Rheinberger, K. and Konigsrainer, A. 2003. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit. Care Med. 31: 1160-1165.
25. Walker, B.R., Haynes, J. Jr., Wang, H.L. and Voelkel, N.F. 1989. Vasopressin-induced pulmonary vasodilation in rats. Am. J. Physiol. 257: H415-H422.
26. Zaslow, I. M. 1984. Veterinary Trauma and Critical Care. Lea & Febiger, Philadelphia.
27. Zion, M.M., Balkin, J., Rosenmann, D., Goldbourt, U., Reicher-Reiss, H., Kaplinsky, E. and Behar, S. 1990. Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis of experience in 5,841 patients in the SPRINT registry. SPRINT study group. Chest 98: 1331-1335.